Pricing Log in Create free account

Gelteq Limited (GELS) vs PainReform Ltd. (PRFX)

Gelteq Limited and PainReform Ltd. are both Drug Manufacturers Specialty & Generic companies. Gelteq Limited is the larger, with a market value of $4.9M against $2.3M — 2.1× the size. Across the 5 metrics below, PainReform Ltd. leads on 3 and Gelteq Limited on 2.

Valuation

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S — n/m 2.08
P/B n/m 0.00 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 0.97 12.22
EV/Sales n/m n/m 2.87
Earnings yield — (156,798.70%) (15.94%)
Free cash flow yield 0.00% (101,853.01%) 0.00%

Profitability

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Gross margin — 0.00% 53.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.80%)
Return on assets 0.00% 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 5.22%
EPS growth (last fiscal year) (62.07%) 92.92% 42.91%
Revenue growth, 5-year CAGR — — 7.24%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.00 0.04
Current ratio 0.09 5.07 2.41
Net debt to EBITDA (0.91) 0.96 1.01

Dividend

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Market cap 4.88m 2.31m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack